SIVA YECHOOR: Open Payments
NPI 1538179890 · SYLVANIA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,557 in 88 payments from 23 companies in 2025. Trend: 2023 $1,603 · 2024 $1,891 · 2025 $1,557
Food & beverage: $1,457Education: $100
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 17 | $286 |
| HARMONY BIOSCIENCES LLC | 8 | $249 |
| ABBVIE INC. | 15 | $198 |
| Otsuka America Pharmaceutical, Inc. | 8 | $145 |
| Alkermes, Inc. | 4 | $74 |
| Novo Nordisk Inc | 4 | $65 |
| Sumitomo Pharma America, Inc. | 3 | $58 |
| Corium, LLC | 6 | $55 |
| Teva Pharmaceuticals USA, Inc. | 3 | $47 |
| Vanda Pharmaceuticals Inc. | 3 | $45 |
Products named: INGREZZA, VRAYLAR, WAKIX, REXULTI, ARISTADA, GEMTESA, Azstarys, AUSTEDO XR.
Industry payments across OH — which companies pay providers there.
